Ratings Oneview Healthcare PLC

Equities

ONE

AU000000ONE9

Market Closed - Australian S.E. Other stock markets 02:10:11 2024-05-03 am EDT			5-day change	1st Jan Change
0.245 ^AUD	-5.77%		-20.97%	+2.08%

Apr. 23	Oneview Healthcare Posts 9% Rise in Net Operating Cashflow in March Quarter	MT
Apr. 02	Oneview Healthcare Inks Master Services Agreement with Inova Health for 1,900 Beds	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

The prospective high growth for the next fiscal years is among the main assets of the company
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
With an enterprise value anticipated at 7.07 times the sales for the current fiscal year, the company turns out to be overvalued.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
ONEVIEW HEALTHCARE PLC	+2.08%	109M	-
ORACLE CORPORATION	+9.84%	318B	B-
SAP SE	+22.40%	213B	B+
SERVICENOW, INC.	+1.44%	147B	B
CONSTELLATION SOFTWARE INC.	+10.74%	56.34B	D+
HUBSPOT, INC.	+3.40%	30.56B	B+
FAIR ISAAC CORPORATION	+2.49%	29.48B	C+
MICROSTRATEGY INCORPORATED	+93.63%	21.69B	D+
WISETECH GLOBAL LIMITED	+22.42%	20.19B	B-
SAGE GROUP PLC	+0.90%	14.83B	B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes